Assenagon Asset Management S.A. Fulgent Genetics, Inc. Transaction History

Assenagon Asset Management S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$47.98 - $62.75 $166,730 - $218,056	3,475 Added 12.65%	30,949 $1.69 Million
Q1 2022 Apr 25, 2022	BUY	$49.85 - $96.11 $488,181 - $941,205	9,793 Added 55.39%	27,474 $1.72 Million
Q4 2021 Feb 01, 2022	BUY	$77.3 - $105.0 $128,704 - $174,825	1,665 Added 10.4%	17,681 $1.78 Million
Q3 2021 Oct 19, 2021	SELL	$74.87 - $110.87 $124,958 - $185,042	-1,669 Reduced 9.44%	16,016 $1.44 Million
Q2 2021 Jul 15, 2021	BUY	$66.8 - $100.45 $1.18 Million - $1.78 Million	17,685 New	17,685 $1.63 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.